News and Announcements
IntelliHR Holdings Limited (ASX: IHR) achieve greatest sales in their history
- Published July 10, 2018 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
KEY TAKEAWAYS:
- intelliHR Holdings Limited (ASX: IHR) have achieved the highest quarterly sales in its history.
- The customer use rate for their platform grew by 300%.
- Additional staff and clients allow for the continual growth during this quarter.
intelliHR has announced its strongest quarterly sales achievement in their history. The company merge the automation of HR process with data analytics to create a cloud-based people management platform. The company’s customer usage for their people management and data analytics platform grew by 300% in their previous best quarter. intelliHR successfully debuted on the ASX in January 2018 after raising $4.5 million in an oversubscribed initial public offering (IPO).
The company attained nine new customers this past quarter. With the addition of new staff and the new clients, the company is demonstrating their capacity to scale up for growth. The recent customer acquisitions include Change Accountants and Advisers who ranked in the Australian Financial Review’s Top 100 Accountants in 2017 and are also Xero’s number one accounting partner in Queensland. They also gained clients Mutual Marketplace, SevenTwenty, Volunteering SA & NT and Marra Worra Worra Aboriginal Corporation in Western Australia.
The intelliHR Partner Program, a way to enhance the relationship with clients, is also growing with a total of 8 partners now participating in the program.
About intelliHR (ASX: IHR)
intelliHR is a human resources (HR) technology business, which has developed a cloud-based people management platform designed analytics-first. An early stage innovative technology business, intelliHR is fast demonstrating a competitive and market leading product by delivering a real return on investment for our customers leading to business transformation.
Company Updates
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
